Thierry Naas

Université Paris-Saclay, Gif-sur-Yvette, Île-de-France, France 
"Thierry Naas"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Emeraud C, Mahamat A, Jousset AB, et al. (2023) Emergence and rapid dissemination of highly resistant NDM-14-producing ST147, France, 2022. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 28
Denakpo E, Naas T, Iorga BI. (2023) An updated patent review of metallo-β-lactamase inhibitors (2020-2023). Expert Opinion On Therapeutic Patents. 33: 523-538
Gaillot S, Oueslati S, Vuillemenot JB, et al. (2023) Genomic characterization of an NDM-9-producing clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9. Frontiers in Microbiology. 14: 1253160
Rima M, Pfennigwerth N, Cremanns M, et al. (2023) In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates. Antibiotics (Basel, Switzerland). 12
Jousset AB, Bouabdallah L, Birer A, et al. (2023) Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France. Emerging Infectious Diseases. 29: 1877-1881
Kassem II, Osman M, Hassan J, et al. (2023) First Report of the Mobile Colistin Resistance Gene, mcr-1.26, in Multidrug-Resistant Escherichia coli Isolated from Retail Chicken Meat. Journal of Global Antimicrobial Resistance
Naas T, Dabos L, Bonnin RA. (2023) β-Lactamase Genes without Limits. Microorganisms. 11
Bonnin RA, Bernabeu S, Emeraud C, et al. (2023) In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales. Antibiotics (Basel, Switzerland). 12
Dabos L, Raczynska JE, Bogaerts P, et al. (2023) Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant. Antimicrobial Agents and Chemotherapy. e0109522
Oueslati S, Bogaerts P, Dortet L, et al. (2022) In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium. Antibiotics (Basel, Switzerland). 11
See more...